All-trans retinoic acid (ATRA) or mesenchymal stem cells (MSCs) have been shown to promote lung tissue regeneration in animal models of emphysema. However, the reparative effects of the combination of the two and the role of p70S6 kinase-1 (p70S6k1) activation in the repair process have not been defined. Twenty-one days after intratracheal instillation of porcine pancreatic elastase (PPE), MSC and/or 10 days of ATRA treatment was initiated. Thirty-two days later, static lung compliance (Cst), mean linear intercepts (MLIs), and alveolar surface area (S) were measured. After PPE, mice demonstrated increased values of Cst and MLI, and decreased S values. Both ATRA and MSC transfer were individually effective in improving these outcomes while the combination of ATRA and MSCs was even more effective. The combination of p70S6k1 2/2 MSCs transfer followed by ATRA demonstrated only modest effects, and rapamycin treatment of recipients with wild-type (WT) MSCs and ATRA failed to show any effect. However, transfer of p70S6k1 over-expressingMSCs together with ATRA resulted in further improvements over those seen following WT MSCs together with ATRA. ATRA activated p70S6k1 in MSCs in vitro, which was completely inhibited by rapamycin. Tracking of transferred MSCs following ATRA revealed enhanced accumulation and extended survival of MSCs in recipient lungs following PPE but not vehicle instillation. These data suggest that in MSCs, p70S6k1 activation plays a critical role in ATRA-enhanced lung tissue repair, mediated in part by prolonged survival of transferred MSCs. p70S6k1-activated MSCs may represent a novel therapeutic approach to reverse the lung damage seen in emphysema. STEM CELLS TRANSLATIONAL MEDICINE 2018;7:551-558 
INTRODUCTION
Emphysema is one phenotype of chronic obstructive pulmonary disease (COPD), a worldwide problem with an estimated 65 million people affected and more than 3 million deaths annually [1] . The principal causes of emphysema are cigarette smoking (primarily) and alpha-1 antitrypsin deficiency (AATD) [2, 3] . AATD is a genetic disorder; the number of people with AATD is estimated at 100,000 in the United States, and patients who develop early onset emphysema have a poor prognosis. Treatments for emphysema do not have sustained clinical benefit and do not lead to the repair of underlying pulmonary parenchymal damage. Lung transplantation remains the primary therapeutic option in severe cases and is limited in its utility due to complications, costs, and number of available donors [4] .
Mesenchymal stem cells (MSCs) are found in tissues and organs, and their primary role is to maintain and repair damaged tissue, including lung tissue [5] . MSCs can be derived from bone marrow and differentiated into a variety of mesenchymal cell types, including fibroblasts, myofibroblasts, osteoblasts, chondroblasts, adipocytes, myoblasts, and also epithelial cells [6, 7] . MSCs possess low immunogenicity and can be adoptively transferred into the host, even allogeneically [7] , an advantage in the clinical setting. In rodent models of emphysema, transplantation of MSCs has shown significant repair benefits [8] [9] [10] . In acute lung injury models, adoptive transfer of MSCs demonstrated immunomodulatory effects and were shown to differentiate into alveolar epithelial cells in a papain-induced emphysema model in rats [11] . However, the role of MSCs in the repair of lung tissue damage has not been well defined. Clinical studies with MSCs in the treatment of COPD patients are underway, but studies are critically needed to identify when and in what type of lung disease treatment with MSCs can be most successfully applied [12] .
All-trans retinoic acid (ATRA), a retinoid, is structurally related to Vitamin A and has multiple roles in tissues, including modulation of the structure and function of a variety of inflammatory, immune, and structural cells, and the development of organs, including lungs [13] . ATRA has been shown to reverse lung tissue damage in an elastase-induced rat emphysema model, and retinoids have been shown to play a role in lung development [14, 15] . Despite these findings, similar studies in mouse models of elastase-induced emphysema and in clinical studies, demonstrated that ATRA treatment alone failed to show these effects [16] [17] [18] . Retinoic acid has also been shown to play a critical role in differentiating stem cells through ligation of retinoic acid receptors followed by homodimerization with retinoid X receptors which activate transcription factors [19] . However, the signaling pathways and functional alteration of MSCs following retinoid stimulation in the repair of lung tissue have not been fully defined.
S6 kinase (S6k) is a key downstream substrate of the mammalian target of rapamycin (mTOR). The mTOR/S6k signaling pathway contributes to several pathological conditions, including diabetes, cancer, obesity, and emphysema [20] [21] [22] The pivotal role of mTOR in the functional differentiation of MSCs has been also demonstrated [23, 24] . The mTOR/S6k axis stimulates protein synthesis, cell growth, and survival [25] . To date, two highly homologous S6ks have been reported: S6k1 and S6k2 [26] . S6k1 and S6k2 are phosphorylated by a specific hetelotrimetric complex including mTOR (mTORC1 and mTORC2, respectively). The mTORC1-S6k1 axis has been shown to control fundamental cellular processes, including transcription, translation, protein and lipid synthesis, cell growth/size, cell metabolism including induction of wound healing, gastric epithelial cell migration, and promotion of differentiation and regeneration of neurons [25] [26] [27] [28] . To date, three isoforms of S6k1 have been reported: p70S6k1, p85S6k1, and p31S6k1. Among these isoforms, p70S6k1 has been reported as predominate and is the only isoform regulated by a growth factor [25] [26] [27] [28] . Previously, we reported the outcomes of p70S6k1 deficiency at the cellular level and showed that rapamycin blocked protein synthesis through inhibition of the S6k1 signaling pathway [29] . Despite these functions of p70S6k1, p70S6k1-deficient mice appeared to be relatively normal except for a slightly smaller body size [30] . Since the mTORC1-S6k1 signaling pathway plays a critical role in lung development and mTOR plays a preventive role in cigarette smoking-induced emphysema [21] , the role of p70S6k1 in the repair of damaged lung tissue was determined in this study.
In a mouse model of elastase-induced emphysema, emphysematous changes progressed gradually for up to 10 months following a single administration of elastase [31] . Thus, the elastaseinduced emphysema model may reproduce some of the pathogenic events seen with progressive emphysema in smoking-or AATD-associated COPD. Excessive neutrophil elastase activity has been associated with the progression of COPD [32] . In light of the potential for beneficial interactions between MSCs, ATRA, and p70S6k1 in the repair of damaged lung tissue, we investigated the effects of combining treatment with MSC transfer and ATRA administration on elastase-induced emphysema in settings where p70S6k1 activity was enhanced by overexpression or reduced by genetic or pharmacologic manipulation. Although advanced methodologies for isolation of bone marrow MSCs have been developed and different characteristics have been described for isolated and cultured MSCs, conventional MSC isolation and expansion in culture should remain a valid approach for studying potential clinical applications [33] . In this setting, we hypothesized that ATRA would enhance the repair activity of MSCs in emphysema through the activation of p70S6k1.
MATERIALS AND METHODS

Animals
Female C57Bl/6 wild-type (WT) mice were purchased from Jackson Laboratories (Bar Harbor, ME) and used at 8-10 weeks of age. This age and gender were chosen as body sizes and lung volume, which affect lung function values, are less variable compared to male or older mice. p70S6k1-deficient (S6k1 2/2 ) mice, created previously by homologous recombination, were genotyped and maintained on an inbred C57Bl/6 background as previously described [30] . Transgenic mice expressing tdTomato B6.CgGt(RO-SA)26Sortm14(CAGtdTomato)Hze/J (tdTomato mice) were provided by Dr. Jordan Jacobelli at National Jewish Health, Denver, CO. All of the mice were housed under specific pathogen-free conditions. Experiments were conducted under a protocol approved by Institutional Animal Care and Use Committee of National Jewish Health.
Reagent
ATRA (Cayman Chemical, Ann Arbor, MI) was dissolved in cottonseed oil and administered to mice at a dose of 500 mg/kg by i. 
Development and Evaluation of Elastase-Induced Emphysema
Mice were anesthetized with isoflurane, and 120 U/kg of PPE (Elastin Products Company, Owensville, MO) dissolved in 40 ll of physiological saline solution was instilled via the trachea without causing any adverse health events. Control mice received saline alone. Thirty-two days after elastase administration, lung function was measured. Mice were euthanized using pentobarbital and the inserted tracheal cannula was attached to a FlexiVent system (Scireq, Montreal, Canada) to ventilate and analyze lung function. Pressure-volume curves were generated and static compliance (Cst) and total lung capacity (TLC) were calculated using FlexiVent software. After lung function measurements, lung tissues were collected for further morphometric analysis to determine the degree of emphysematous changes. Slides of left lung tissue were stained by hematoxylin-eosin and analyzed for mean linear intercept (MLI) according to the guidelines of the American Thoracic Society/European Respiratory Society [35] . The slide images of peripheral lung tissues along visceral pleura were captured using a microscope (BX40; Olympus America, Melville, NY) equipped with a digital camera (Q-color 3; Olympus America, Center Valley, PA). Meanfree distance was quantified as MLI in the captured images by randomly set test lines using NIH Image J (available at http://imagej. nih.gov/ij/download.html). Values of alveolar surface area (S) were also calculated with MLI and TLC as described previously [36] .
Lentiviral Transduction of p70S6k1 in MSC
The p70S6k1 open-reading frame expression clone was purchased from Genecopoeia (Rockville, MD) and used along with the LentiPac HIV Expression Packaging Kit (Genecopoeia) according to the manufacturer's instructions to produce recombinant lentivirus. The 293Ta packaging cell line was transfected overnight with the p70S6k1 expression clone and packaging plasmids. After 16 hours, fresh medium was added to the cells and incubated overnight. Pseudoviral supernatants were then collected at 24 and 48 hours post-transfection and used for transduction. MSCs were plated in 6 well plates (1 3 10 6 cells per well) and viral supernatants (4 ml) containing 10 mM HEPES pH 7.4 (Life Technologies, Carlsbad, CA) and 7 lg/ml polybrene (Sigma-Aldrich) were added to the cells. The plates were centrifuged at room temperature for 1 hour at 2,000 rpm (spinfection). The viral supernatants were removed and replaced with fresh medium. The cells were incubated overnight at 378C. This centrifuge/incubation step was repeated two additional times. After the third spinfection, the cells were allowed to expand for 2 days and positively selected using 100 lg/ml Geneticin (Life Technologies).
Immunoblot Analysis
Cells were washed with PBS and analyzed for levels of whole protein or phosphorylated p70S6k1 by Western blot. Washed cells were lysed in RIPA buffer containing protease and a phosphatase inhibitor (Halt Protease Inhibitor Cocktail; Thermo Fisher Scientific, Inc., Waltham, MA). After debris was removed by centrifugation, Laemelli buffer (Bio-Rad, Hercules, CA) was added 1:1 to the cell lysates. Lysates were boiled and then run on a 4%-15% precast gradient gel (Bio-Rad) at 150 V at room temperature. The proteins were then electrophoretically transferred to a nitrocellulose membrane at 100 V for 1 hour at 48C. Following transfer, the membrane was washed twice in Tris-buffered saline with 0.1% Tween 20 (TBST), blocked for 1 hour at room temperature in 2% Bovine Serum Albumin, 0.5% sodium azide in TBST, and then incubated overnight at 48C with antibody against p70S6k1 (ab9366; AbCam, Cambridge, MA) or phosphorylated p70S6k1 at T389 (ab2571; AbCam). Anti-b-actin (Sigma-Aldrich) was used as a loading control. After incubation with the primary antibody, the membranes were incubated with anti-rabbit horseradish peroxidase antibody (GE Healthcare Bio-Sciences, Pittsburgh, PA) for 1 hour at room temperature and then washed extensively with TBST. Detection was performed using Western Lightening ECL (Perkin-Elmer, Waltham, MA).
Flow Cytometry Analysis
To track transferred MSCs in lung tissue, lung cells were isolated by collagenase digestion following i.v. injection of MSCs derived from tdTomato mice. Numbers of tdTomato1 cells were monitored using the BD LSRFortessa (BD Biosciences, San Jose, CA).
Statistical Analysis
Values for all measurements were expressed as means 6 SEM. For comparisons between multiple groups, the Tukey-Kramer test was used. Nonparametric analyses, using the Mann-Whitney U test or Kruskal-Wallis test, were also applied to confirm that statistical differences remained significant, even if the underlying distribution was uncertain. The p value for significance was set at less than .05.
RESULTS
Effects of the Combination of ATRA and MSCs on Elastase-Induced Emphysema
To investigate the outcomes of the combination of ATRA and MSCs on the reversal of emphysematous tissue damage induced by PPE, MSCs were adoptively transferred into mice 21 days after intratracheal instillation of elastase followed by ATRA administration for 10 consecutive days. As shown in Figure 1A , elastase instillation induced significant peripheral airway destruction which resulted in increased MLI (Fig. 1B) and decreased alveolar surface area (S) (Fig. 1C) . ATRA or MSC alone demonstrated modest effects on reduction of peripheral lung tissue damage as seen histologically and by decreases in MLI or increases in S values compared to the vehicle-treated group. When the results of the combination of MSCs and ATRA were determined, the extent of Takeda, Ning, Domenico et al. (Fig. 1C) . As a measure of lung function, Cst values were increased in the vehicle-treated group following elastase instillation, MSC, or ATRA treatment alone showed decreased Cst values, and the combination was significantly more effective.
Role of p70S6k1 in MSC-Induced Lung Tissue Improvement
To determine whether p70S6k1 played a role in the reparative function of MSCs, MSCs derived from the bone marrow of S6k1 2/2 mice were adoptively transferred into WT mice 21 days after PPE instillation. As a control, MSCs derived from WT mice were similarly transferred. As shown in Figure 2A , recipients of S6k1 2/2 MSCs followed by ATRA treatment demonstrated limited effects on PPE-induced tissue damage, as MLI were significantly higher and S values were lower than in the group which received WT MSCs and ATRA treatment (Fig. 2B, 2C ). In parallel, Cst values were not significantly decreased by transferred S6k1 2/2 MSCs followed by ATRA treatment (Fig. 2D ).
In light of the known effects of rapamycin on p70S6K1 activation [21] , we examined whether rapamycin altered MSC/ATRAinduced repair by administering the inhibitor following MSC transfer and during the ATRA treatment days. As shown in Figure 2E -2G, both MLI and Cst values in rapamycin-treated mice remained high, whereas S values remained low compared to the vehicletreated group. These results implicated the role of p70S6k1 in the improvement of damaged lung tissue.
To establish that the effects of rapamycin were mediated through inhibition of ATRA stimulation of p70S6k1 in MSCs, protein levels of phosphorylated p70S6k1 were examined in MSCs cocultured with ATRA. As shown in Figure 2H , phosphorylated p70S6k1 was increased compared to vehicle-treated cells 12 hours after coculture with ATRA. Rapamycin pretreatment attenuated the activation of p70S6k1 in MSCs cocultured with ATRA. Phosphorylated p70S6k1 was not detected at 3 or 6 hours of ATRA stimulation (data not shown). Thus, one consequence of ATRA treatment was activation of p70S6k1, which appeared essential to the reparative activity of the MSCs.
Over-Expression of p70S6k1 in MSCs/ATRA Improved Lung Tissue Damage
To further establish the role of p70S6k1 in the MSC/ATRA effects on damaged lung tissue, p70S6k1 was over-expressed in MSCs followed by adoptive transfer into mice 21 days after PPE. As shown in Figure 3A , p70S6k1 protein levels were upregulated following lentivirus transfection compared with empty vector-treated cells. Morphometric and physiological analyses revealed significantly lower MLI and Cst values and significantly higher S values in lungs of mice, which received p70S6k1 over-expressing MSCs compared with mice that received WT MSCs (Fig. 3B, 3C ).
Effects of ATRA Treatment on the Number of Transferred MSCs in Lung Tissue
To determine the effects of ATRA treatment on the survival of MSCs in lung tissue, labeled MSCs were tracked and the number of cells in the lungs was monitored. Figure 4A and 4B, the numbers of tdTomato 1 MSCs were significantly increased in mice which received ATRA compared to recipients of vehicle at 48 hours, 72 hours, and 7 days after MSC transfer. However, when MSCs were transferred into mice following saline instillation, numbers of tdTomato 1 MSCs were significantly decreased regardless of ATRA treatment.
DISCUSSION
In the present study, the significant benefits of combining MSCs and ATRA in an experimental model of emphysema were demonstrated, as well as a critical role of the p70S6k1-signaling pathway in this process. First, we demonstrated that treatment with either MSCs or ATRA alone showed modest effects on physiological and histological outcomes expressed as Cst, MLI, and S values. However, when MSCs were adoptively transferred, followed by ATRA administration, the improvements were greater. To address the role of p70S6k1 in this reparative process, S6k1 2/2 MSCs were transferred followed by ATRA treatment and compared to the benefits of transfer of WT MSCs on elastase-induced emphysema. In contrast to the benefits of WT MSCs, S6k1 2/2 MSCs had limited effects on damaged lungs. Addition of ATRA to MSCs in vitro resulted in increased p70S6k1 phosphorylation in WT MSCs. Rapamycin inhibits activation of the mTOR-p70S6k1 pathway [21, 25] and when added to ATRA-treated MSCs, phosphorylation of p70S6k1 was attenuated. To confirm the role of p70S6k1 activation, mice were treated with rapamycin. Similar to the results of transfer of S6k1 2/2 MSCs, rapamycin administration prevented the reversal of lung tissue damage seen with WT MSCs/ATRA. As a corollary to these findings, transfer of p70S6k1-overexpressing MSCs into PPE-treated mice, followed by ATRA administration, normalized lung function, and histological findings. An additional feature of ATRA treatment of MSCs was the enhanced accumulation and prolonged residence time of labeled and transferred cells in the lung following elastase but not vehicle instillation. Massaro et al. initially reported that ATRA administration repaired damaged lung tissue in a rat model of emphysema [14] . This study fostered clinical trials with ATRA or pharmacologically [18] . In animal models of emphysema, findings following treatment with ATRA alone have been inconsistent. Unlike in rats [14] , positive results with ATRA were not seen in elastase or cigarette smoking-induced mouse models of emphysema [16, 17] . In the current study, only modest levels of tissue repair were seen with ATRA treatment alone.
Stem cell therapy is now a focus of attention in a variety of difficult to treat diseases. MSCs are stem cells, which can be differentiated into different tissues such as bone, cartilage, or adipose tissue [37] . As MSCs express low levels of HLA class II molecules, exogenous MSCs are able to escape allorecognition; thus, MSCs can be transferred between different species [37, 38] . Based on these properties, exogenous MSCs have been used to engraft and repair damaged tissue. However, recent studies revealed that the primary function of the transferred MSCs were immunomodulatory through the release of numerous factors [12, 39] . MSCs have been studied in many models of lung disease [40] , including the ability to reverse the consequences of induced lung damage and emphysema. Katsha et al. showed that intratracheal instillation of bone marrow-derived MSCs reduced MLI values in elastaseinduced emphysema in mice [9] . Their study also suggested that factors secreted from MSCs such as hepatocyte growth factor, epidermal growth factor, or secretory leukocyte protease inhibitor may play roles in the repair process. MSCs derived from a different tissue, such as adipose tissue, showed benefits when transferred into mice, which developed emphysema as a consequence of cigarette smoke exposure, and also in elastase-induced emphysema in rats [8, 41] . It is likely that treatment with MSCs from different sources, generations, or culture conditions can result in variable outcomes [10] . To counter this, we used a standardized and established MSC protocol and showed that transfer of MSCs alone had limited efficacy. Administration of ATRA to the MSC recipients enhanced the beneficial effects. MSCs were shown to be short-lived in the recipients after administration [8] . As p70S6k1 has been associated with cell survival and migration of mesenchymal cells [42, 43] , we hypothesized that ATRA treatment may extend the survival and/or enhance the accumulation of MSCs to further augment improvements to damaged lung tissue. Based on the cell tracking studies of labeled MSCs, the number of cells and lung residence time were increased in the recipients that received ATRA treatment (in mice that received PPE but not vehicle alone). As the beneficial effects of MSCs have been associated with their secretion of numerous factors in a paracrine manner [12] , a longer presence in the lung may be a major contributor to the repair of damaged lung tissue.
S6k is a major downstream target of mTOR, and this pathway plays an important role in protein synthesis, cell proliferation, and cell cycle progression [44] . mTOR plays a critical role in lung development [25] , and upregulation of mTOR was shown to protect against development of cigarette smoke-induced emphysema [21] . In the current study, failure to show lung tissue improvement by S6k1 2/2 MSCs, as well as the inhibition of the effects of WT MSCs by rapamycin supported the critical role of the mTOR/ p70S6k1 pathway in the MSC/ATRA-induced improvement of damaged lung tissue. p70S6k1 was phosphorylated in MSCs following ATRA stimulation, which was blocked by rapamycin pretreatment, demonstrating that activation of mTOR/p70S6k1 is a downstream event of ATRA as observed in a study of neurons [45] . The importance of the role of p70S6k1 in MSCs on lung tissue repair was further demonstrated with greater improvements shown following the transfer of p70S6k1-overexpressing MSCs.
CONCLUSION
The findings demonstrated that a combination of MSCs and ATRA was greater than either alone in inducing the improvement of elastase-induced emphysema in mice ( 
